Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenshe Ray Liu

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Journal of Translational Medicine|June 18, 2026
Precise control of switchable chimeric antigen receptor T cells allows enhanced safety and less T cell exhaustionZihan Anna Zhang, Logan Herring, Thuzar Hla Shwe, et al.
Angewandte Chemie (International Ed. in English)|November 16, 2021
A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T CellsWenyue Cao, Zhi Zachary Geng, Na Wang, et al.
Journal of Molecular Biology|March 12, 2022
A Designed, Highly Efficient Pyrrolysyl-tRNA Synthetase Mutant Binds o-Chlorophenylalanine Using Two Halogen BondsErol C Vatansever, Kai S Yang, Zhi Zachary Geng, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2026
Disulfide bond formation between Cys22 and Cys44 in SARS-CoV-2 main proteaseLauren R Blankenship, Kai Yang, Chia-Chuan Dean Cho, et al.
Journal of Medicinal Chemistry|November 12, 2024
Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid LeukemiaXuejiao Shirley Guo, Sandeep Atla, Satyanarayana Nyalata, et al.
ACS Chemical Biology|April 27, 2026
Site-Specific Immobilization of ZNRF3 Reveals the Importance of Target Structural Integrity on Macrocyclic Peptide SelectionsDemonta D Coleman, Linnette Arceo, Armita Paydar, et al.
Nature Communications|April 29, 2026
NAE1/UBA3-UBE2M are E1 and E2 enzymes for the URM1 modificationSwatadipta Chakraborty, Saibal Chanda, Zhongwen Cao, et al.
Frontiers in Chemistry|March 7, 2022
An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound LibraryShuhua G Li, Kai S Yang, Lauren R Blankenship, et al.
Nature|September 10, 2020
The molecular basis of tight nuclear tethering and inactivation of cGASBaoyu Zhao, Pengbiao Xu, Chesley M Rowlett, et al.
Chemmedchem|February 8, 2022
Corrigendum: Drug Repurposing for the SARS-CoV-2 Papain-Like ProteaseChia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Journal of Translational Medicine|June 18, 2026
Precise control of switchable chimeric antigen receptor T cells allows enhanced safety and less T cell exhaustionZihan Anna Zhang, Logan Herring, Thuzar Hla Shwe, et al.
Angewandte Chemie (International Ed. in English)|November 16, 2021
A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T CellsWenyue Cao, Zhi Zachary Geng, Na Wang, et al.
Journal of Molecular Biology|March 12, 2022
A Designed, Highly Efficient Pyrrolysyl-tRNA Synthetase Mutant Binds o-Chlorophenylalanine Using Two Halogen BondsErol C Vatansever, Kai S Yang, Zhi Zachary Geng, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2026
Disulfide bond formation between Cys22 and Cys44 in SARS-CoV-2 main proteaseLauren R Blankenship, Kai Yang, Chia-Chuan Dean Cho, et al.
Journal of Medicinal Chemistry|November 12, 2024
Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid LeukemiaXuejiao Shirley Guo, Sandeep Atla, Satyanarayana Nyalata, et al.
ACS Chemical Biology|April 27, 2026
Site-Specific Immobilization of ZNRF3 Reveals the Importance of Target Structural Integrity on Macrocyclic Peptide SelectionsDemonta D Coleman, Linnette Arceo, Armita Paydar, et al.
Nature Communications|April 29, 2026
NAE1/UBA3-UBE2M are E1 and E2 enzymes for the URM1 modificationSwatadipta Chakraborty, Saibal Chanda, Zhongwen Cao, et al.
Frontiers in Chemistry|March 7, 2022
An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound LibraryShuhua G Li, Kai S Yang, Lauren R Blankenship, et al.
Nature|September 10, 2020
The molecular basis of tight nuclear tethering and inactivation of cGASBaoyu Zhao, Pengbiao Xu, Chesley M Rowlett, et al.
Chemmedchem|February 8, 2022
Corrigendum: Drug Repurposing for the SARS-CoV-2 Papain-Like ProteaseChia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Pageof 7